Invention Grant
- Patent Title: Antitumor derivatives for differentiation therapy
-
Application No.: US15915444Application Date: 2018-03-08
-
Publication No.: US10370373B2Publication Date: 2019-08-06
- Inventor: Yogenthiran Saunthararajah , Kwok Peng Ng , James G. Phillips , Babal Kant Jha , Anand Dev Tiwari
- Applicant: THE CLEVELAND CLINIC FOUNDATION
- Applicant Address: US OH Cleveland
- Assignee: THE CLEVELAND CLINIC FOUNDATION
- Current Assignee: THE CLEVELAND CLINIC FOUNDATION
- Current Assignee Address: US OH Cleveland
- Agency: Tarolli, Sundheim, Covell & Tummino LLP
- Main IPC: C07D401/02
- IPC: C07D401/02 ; C07D401/10 ; A61K31/437 ; A61K31/4353 ; C07D471/04

Abstract:
Imidazopyridine derivatives according to formula I are described wherein X is selected from CH, N, S, and O, Y is selected from S, CO, and O, R1 and optional R2 are independently selected from H, OH, substituted or unsubstituted C1-C6 alkyl, and substituted or unsubstituted C4-C6 cycloalkyl or cycloheteroalkyl, R3 is selected from H, OH, substituted or unsubstituted C1-C6 alkyl, and optional Z is selected from OH, NH2, NH(CO)R4, NH(SO2)R4, guanidine, alkylguanidine, and fluoroguanidine, R4 is polyethylene glycol or substituted or unsubstituted C1-C6 alkyl, and pharmaceutically acceptable salt thereof. The imidazopyridine derivatives can be used for treatment of cancer in a subject.
Public/Granted literature
- US20180194764A1 ANTITUMOR DERIVATIVES FOR DIFFERENTIATION THERAPY Public/Granted day:2018-07-12
Information query